BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 19009290)

  • 1. Accuracy of whole-body low-dose multidetector CT (WBLDCT) versus skeletal survey in the detection of myelomatous lesions, and correlation of disease distribution with whole-body MRI (WBMRI).
    Gleeson TG; Moriarty J; Shortt CP; Gleeson JP; Fitzpatrick P; Byrne B; McHugh J; O'Connell M; O'Gorman P; Eustace SJ
    Skeletal Radiol; 2009 Mar; 38(3):225-36. PubMed ID: 19009290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of whole-body low-dose computed tomography (WBLDCT) in bone lesions detection in patients with multiple myeloma (MM).
    Ippolito D; Besostri V; Bonaffini PA; Rossini F; Di Lelio A; Sironi S
    Eur J Radiol; 2013 Dec; 82(12):2322-7. PubMed ID: 24074647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radiological diagnostics of multiple myeloma].
    D'Anastasi M; Grandl S; Reiser MF; Baur-Melnyk A
    Radiologe; 2014 Jun; 54(6):556-63. PubMed ID: 24927658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Whole Body Low Dose Computed Tomography (WBLDCT) Can Be Comparable to Whole-Body Magnetic Resonance Imaging (WBMRI) in the Assessment of Multiple Myeloma.
    Ippolito D; Giandola T; Maino C; Gandola D; Ragusi M; Bonaffini PA; Sironi S
    Diagnostics (Basel); 2021 May; 11(5):. PubMed ID: 34064594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective study of Skeletal survey versus Low-dose whole-body CT for Osteolytic lesions in Multiple Myeloma.
    Gundesen MT; Asmussen JT; Haukås E; Schubert M; Abildgaard N; Schjesvold F; Lund T
    Eur J Haematol; 2022 May; 108(5):423-429. PubMed ID: 35113466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-body magnetic resonance imaging (WBMRI) versus whole-body computed tomography (WBCT) for myeloma imaging and staging.
    Treitl KM; Ricke J; Baur-Melnyk A
    Skeletal Radiol; 2022 Jan; 51(1):43-58. PubMed ID: 34031705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging of neuroendocrine tumours: comparison of [⁶⁸Ga]DOTATOC multiphase PET/CT and whole-body MRI.
    Schraml C; Schwenzer NF; Sperling O; Aschoff P; Lichy MP; Müller M; Brendle C; Werner MK; Claussen CD; Pfannenberg C
    Cancer Imaging; 2013 Mar; 13(1):63-72. PubMed ID: 23466785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of whole body magnetic resonance imaging (WBMRI) to whole body computed tomography (WBCT) or
    Gariani J; Westerland O; Natas S; Verma H; Cook G; Goh V
    Crit Rev Oncol Hematol; 2018 Apr; 124():66-72. PubMed ID: 29548488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Whole-body ultra-low dose CT using spectral shaping for detection of osteolytic lesion in multiple myeloma.
    Suntharalingam S; Mikat C; Wetter A; Guberina N; Salem A; Heil P; Forsting M; Nassenstein K
    Eur Radiol; 2018 Jun; 28(6):2273-2280. PubMed ID: 29322333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Whole-body low-dose computed tomography (WBLDCT) in staging and re-staging of multiple myeloma.
    Ippolito D; Giandola T; Maino C; Pecorelli A; Ragusi M; Porta M; Gandola D; Franzesi CT; Sironi S
    Ann Hematol; 2021 May; 100(5):1241-1249. PubMed ID: 33660034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Body Low-Dose CT in Multiple Myeloma: Diagnostic Value of Appendicular Medullary Patterns of Attenuation.
    Koutoulidis V; Terpos E; Klapa I; Cheliotis G; Ntanasis-Stathopoulos I; Boultadaki A; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
    AJR Am J Roentgenol; 2021 Mar; 216(3):742-751. PubMed ID: 33439048
    [No Abstract]   [Full Text] [Related]  

  • 12. Organ dose and total effective dose of whole-body CT in multiple myeloma patients.
    Hemke R; Yang K; Husseini J; Bredella MA; Simeone FJ
    Skeletal Radiol; 2020 Apr; 49(4):549-554. PubMed ID: 31612246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation exposure and establishment of diagnostic reference levels of whole-body low-dose CT for the assessment of multiple myeloma with second- and third-generation dual-source CT.
    Zensen S; Bos D; Opitz M; Haubold J; Forsting M; Guberina N; Wetter A
    Acta Radiol; 2022 Apr; 63(4):527-535. PubMed ID: 33745295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Whole-body MR imaging in suspected physical child abuse: comparison with skeletal survey and bone scintigraphy findings from the PEDIMA prospective multicentre study.
    Proisy M; Vivier PH; Morel B; Bruneau B; Sembely-Taveau C; Vacheresse S; Devillers A; Lecloirec J; Bodet-Milin C; Dubois M; Hamonic S; Bajeux E; Ganivet A; Adamsbaum C; Treguier C;
    Eur Radiol; 2021 Nov; 31(11):8069-8080. PubMed ID: 33912993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.
    Pianko MJ; Terpos E; Roodman GD; Divgi CR; Zweegman S; Hillengass J; Lentzsch S
    Clin Cancer Res; 2014 Dec; 20(23):5888-97. PubMed ID: 25294899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the diagnostic performance and impact on management of 18F-FDG PET/CT and whole-body MRI in multiple myeloma.
    Westerland O; Amlani A; Kelly-Morland C; Fraczek M; Bailey K; Gleeson M; El-Najjar I; Streetly M; Bassett P; Cook GJR; Goh V;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2558-2565. PubMed ID: 33469686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Whole-body low-dose multidetector row-CT in the diagnosis of multiple myeloma: an alternative to conventional radiography.
    Horger M; Claussen CD; Bross-Bach U; Vonthein R; Trabold T; Heuschmid M; Pfannenberg C
    Eur J Radiol; 2005 May; 54(2):289-97. PubMed ID: 15837412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
    Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
    J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of whole-body ultra-low dose computed tomography in comparison with spinal magnetic resonance imaging in the assessment of disease in multiple myeloma.
    Ippolito D; Talei Franzesi C; Spiga S; Besostri V; Pezzati S; Rossini F; Sironi S
    Br J Haematol; 2017 May; 177(3):395-403. PubMed ID: 28233900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inter-observer agreement for the evaluation of bone involvement on Whole Body Low Dose Computed Tomography (WBLDCT) in Multiple Myeloma (MM).
    Zacchino M; Bonaffini PA; Corso A; Minetti V; Nasatti A; Tinelli C; Dore R; Calliada F; Sironi S
    Eur Radiol; 2015 Nov; 25(11):3382-9. PubMed ID: 25987427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.